DeepContour received FDA clearance

On May 8, 2024, Wisdom Technologies, Inc. announced that its product, DeepContour, has received clearance from the FDA, marking another significant advancement towards global market penetration.

DeepContour, an automatic CT image organ contour system, provides predictive results that can be stored in various formats. This system not only streamlines processes through automation but also prioritizes the quality and security of patient information to ensure that patients receive the safest, highest quality, and most efficient treatment available.

Wisdom Technologies takes pride in the recent consecutive clearances of its Quality Assurance (ArcherQA), contouring (DeepContour), and Treatment Planning Systems (DeepPlan) in China and the United States, which underscore its capacity for innovation and technical proficiency. The company remains steadfast in its dedication to serving the global radiotherapy community and contributing to advancements in healthcare.